The Author(s) 2014. This article is published with open access at Springerlink.com Background Hospital-discharged patients with schizoaf-fective disorder have a high risk of re-hospitalization. However, limited data exist evaluating critical post-dis-charge periods during which the risk of re-hospitalization is significant. Objective Among hospital-discharged patients with schizoaffective disorder, we assessed pharmacotherapy adherence and healthcare utilization and costs during sequential 60-day clinical periods before schizoaffective disorder-related hospitalization and post-hospital discharge. Methods From the MarketScan Medicaid database (2004–2008), we identified patients (C18 years) with a schizoaffective disorder-related inpatient a...
Original article can be found at: http://www.chemistanddruggist.co.uk/Schizophrenia affects around o...
Purpose: To describe (1) the clinical profiles and the patterns of use of long-acting injectable (LA...
textabstractBackground: Little data is available on the real-world socio-economic burden and outcome...
Wenjie Zhang,1 Tony B Amos,2 Stephen W Gutkin,1 Nicole Lodowski,1 Emma Giegerich,1 Kruti Joshi2 1WG ...
This document is the author's final accepted version of the journal article. There may be diffe...
This study aimed to assess antipsychotic adherence patterns and all-cause and schizophrenia-related ...
is available at the end of the articleBackground Schizophrenia is a complex neurobehavioral disorder...
Objective: To review the literature addressing the economic outcomes of nonadherence in the treatmen...
Objective: The objective of this study was to evaluate the impact of medication adherence on healthc...
Objective: To study the prevalence of various psychiatric disorders, compile and compare the data wi...
Abstract: This prospective longitudinal 15-year multifollow-up research studied whether unmedicated ...
Introduction: Poor medication adherence among patients with schizophrenia is associated with a high ...
Summary Aim: To assess medication adherence and risk factors for non-adherence in outpatients with s...
Introduction: Relapse of schizophrenia can be caused by patients who do not adhere to medication. Pa...
Clinical and epidemiological studies have reported up to 47 % substance-use disorder (SUD) comorbidi...
Original article can be found at: http://www.chemistanddruggist.co.uk/Schizophrenia affects around o...
Purpose: To describe (1) the clinical profiles and the patterns of use of long-acting injectable (LA...
textabstractBackground: Little data is available on the real-world socio-economic burden and outcome...
Wenjie Zhang,1 Tony B Amos,2 Stephen W Gutkin,1 Nicole Lodowski,1 Emma Giegerich,1 Kruti Joshi2 1WG ...
This document is the author's final accepted version of the journal article. There may be diffe...
This study aimed to assess antipsychotic adherence patterns and all-cause and schizophrenia-related ...
is available at the end of the articleBackground Schizophrenia is a complex neurobehavioral disorder...
Objective: To review the literature addressing the economic outcomes of nonadherence in the treatmen...
Objective: The objective of this study was to evaluate the impact of medication adherence on healthc...
Objective: To study the prevalence of various psychiatric disorders, compile and compare the data wi...
Abstract: This prospective longitudinal 15-year multifollow-up research studied whether unmedicated ...
Introduction: Poor medication adherence among patients with schizophrenia is associated with a high ...
Summary Aim: To assess medication adherence and risk factors for non-adherence in outpatients with s...
Introduction: Relapse of schizophrenia can be caused by patients who do not adhere to medication. Pa...
Clinical and epidemiological studies have reported up to 47 % substance-use disorder (SUD) comorbidi...
Original article can be found at: http://www.chemistanddruggist.co.uk/Schizophrenia affects around o...
Purpose: To describe (1) the clinical profiles and the patterns of use of long-acting injectable (LA...
textabstractBackground: Little data is available on the real-world socio-economic burden and outcome...